Peregrine Pharmaceuticals Inc

Visual Financials
Company Name: Peregrine Pharmaceuticals Inc
Ticker Symbol: PPHM
CIK Number: 0000704562
WWW Address: http://www.peregrineinc.com
CEO: Mr. Steven W. King
No. of Employees: 323
Common Issue Type: CS
Business Description:Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment and diagnosis of cancer.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 3.88 Down -0.07 3.83 3.92 3.99 4.12 3.88 511544
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 175.0 45.1 0.00 -0.88 0.00 0.0 0.0 5.78 - 0.28
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close3.95$
PE Ratio - LTM0.0
Market Capitalisation175.0mil
Latest Shares Outstanding45.1mil
Earnings pS (EPS)-0.88$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee178,421$
Effective Tax Rate0.0%
Float44.9mil
Float as % of Shares Outstanding1.0%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.30%
Research & Devlopment (R&D) as % of Revenue0.50%
Gross Profit Margin33.6%
EBITDA Margin-44.6%
Pre-Tax Profit Margin0.0%
Assets Turnover50.7%
Return on Assets (ROA)-28.9%
Return on Equity (ROE)-63.3%
Return on Capital Invested (ROCI)-63.5%
Current Ratio1.4
Leverage Ratio (Assets/Equity)2.2
Interest Cover-4021.7
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS0.58$
Cash pS0.00$
Book-Value pS1.24$
Tangible Book-Value pS1.19$
Cash Flow pS-0.86$
Free Cash Flow pS-0.92$
KEY FIGURES (LTM): Price info
Price/Book Ratio3.08
Price/Tangible Book Ratio0.00
Price/Cash Flow
Price/Free Cash Flow
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---14.314219,696271,768
4 Weeks4.123.023.1023.521199,9864,199,709
13 Weeks5.402.855.21-26.5-30242,45215,759,435
26 Weeks5.780.500.55601.2592624,23979,902,609
52 Weeks5.780.280.331059.210391,624,646409,410,920
YTD5.780.28-1166.111531,641,779326,714,196
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
3.833.573.302.071.640.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.300.60.37
Income0.0
Dividend0.0
Capital SpendingNA
R&D13.71NA9.75
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %32.4114.512.9
Earnings %0.00.00.0
EPS %0.00.00.0
EPS $0.210.090.06
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio22.16
Current Ratio1.4
Quick Ratio (Acid Test)0.9
Liquidity Ratio (Cash)1.49
Receivables Turnover11.8
Average Collection Period31
Working Capital/Equity48.8
Working Capital pS0.58
Cash-Flow pS-1.07
Free Cash-Flow pS-1.11
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio1.30
Financial Leverage Ratio (Assets/Equity)0.0
Debt Ratio0.0
Total Debt/Equity (Gearing Ratio)0.00
LT Debt/Equity0.00
LT Debt/Capital Invested3.0
LT Debt/Total Liabilities0.0
Interest Cover-4021.7
Interest/Capital Invested0.01
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio1.46
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA-5.59
Enterprise Value (EV)/Free Cash Flow-3.31
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM3.08
Price/Cash Flow Ratio
Price/Free Cash Flow Ratio - LTM
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio-38.4
5-Y Low P/E Ratio-3.4
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS0.00
Current Liabilities pS2.06
Tangible Book Value pS - LTM1.19
Book Value pS - LTM1.24
Capital Invested pS1.19
Cash pS - LTM0.00
Cash Flow pS - LTM-0.86
Free Cash Flow pS - LTM-0.92
Earnings pS (EPS)-0.88
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin-71.64
Free Cash Flow Margin 5YEAR AVG-115.86
Net Profit Margin-0.5
Net Profit Margin - 5YEAR AVRG.-1.4
Equity Productivity1.08
Return on Equity (ROE)-0.6
Return on Equity (ROE) - 5YEAR AVRG.-1.0
Capital Invested Productivity1.08
Return on Capital Invested (ROCI)-1.0
Return on Capital Invested (ROCI) - 5YEAR AVRG.-1.0
Assets Productivity0.50
Return on Assets (ROA)-0.3
Return on Assets (ROA) - 5YEAR AVRG.-0.6
Gross Profit Margin33.6
Gross Profit Margin - 5YEAR AVRG.0.4
EBITDA Margin - LTM-44.6
EBIT Margin - LTM-48.8
Pre-Tax Profit Margin-1.3
Pre-Tax Profit Margin - 5YEAR AVRG.-1.3
Effective Tax Rate0.0
Effective Tax Rate - 5YEAR AVRG.0.0
EFFICIENCY RATIOS
Cash Conversion Cycle250,284
Revenue per Employee178,421
Net Income per Employee
Average Collection Period250,284
Receivables Turnover11.8
Day's Inventory Turnover Ratio
Inventory Turnover1.6
Inventory/Sales57.4
Accounts Payble/Sales10.03
Assets/Revenue2.00
Net Working Capital Turnover2.20
Fixed Assets Turnover1.99
Total Assets Turnover0.5
Revenue per $ Cash1.23
Revenue per $ Plant2.43
Revenue per $ Common Equity1.08
Revenue per $ Capital Invested1.08
Selling, General & Adm/tive (SG&A) as % of Revenue33.5
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue49.1
R&D Expense as % of Revenue - 5YEAR AVRG.49.1

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.